LogicBio Therapeutics to Present at the Jefferies Virtual Gene Editing/Therapy Summit October 2, 2020

Written by Customer Service on September 25, 2020. Posted in Public Companies.

LEXINGTON, Mass., Sept. 25, 2020 (GLOBE NEWSWIRE) — LogicBio Therapeutics, Inc. (Nasdaq:LOGC), a genome editing company focused on developing medicines to durably treat rare diseases in pediatric patients, today announced CEO Fred Chereau will present at the Jefferies Virtual Gene Editing/Therapy Summit on Friday, October 2, 2020 at 11:30 AM, ET.A live audio webcast of the presentation will be available under the “Events and Presentations” section of LogicBio’s website. A replay of the presentation will become available approximately one hour after the event and will be archived for 30 days.About LogicBio TherapeuticsLogicBio Therapeutics is a genome editing company focused on developing medicines to durably treat rare diseases in pediatric patients with significant unmet medical needs using GeneRide™, its proprietary technology...

LogicBio Therapeutics to Present at the 4th Annual Chardan Virtual Genetic Medicines Conference October 5, 2020

Written by Customer Service on September 25, 2020. Posted in Public Companies.

LEXINGTON, Mass., Sept. 25, 2020 (GLOBE NEWSWIRE) — LogicBio Therapeutics, Inc. (Nasdaq:LOGC), a genome editing company focused on developing medicines to durably treat rare diseases in pediatric patients, today announced CEO Fred Chereau will present at the Chardan Virtual Genetic Medicines Conference on Monday, October 5, 2020 at 11 AM, ET.A live audio webcast of the presentation will be available under the “Events and Presentations” section of LogicBio’s website. A replay of the presentation will become available approximately one hour after the event and will be archived for 30 days.About LogicBio TherapeuticsLogicBio Therapeutics is a genome editing company focused on developing medicines to durably treat rare diseases in pediatric patients with significant unmet medical needs using GeneRide™, its proprietary technology platform....

Pretivm Provides Leadership Transition Update

Written by Customer Service on September 25, 2020. Posted in Public Companies.

VANCOUVER, British Columbia, Sept. 25, 2020 (GLOBE NEWSWIRE) — Further to its announcement regarding leadership change in respect of the Chief Financial Officer role (see news release dated August 31, 2020), Pretium Resources Inc. (TSX/NYSE: PVG) (“Pretivm” or the “Company”) announces that Tom S.Q. Yip, Executive Vice President and Chief Financial Officer, will step down from his role as Chief Financial Officer of the Company on September 30, 2020. Mr. Yip will continue to serve as Executive Vice President and assist with an orderly transition until October 30, 2020. Matthew Quinlan, Vice President, Finance, will succeed Mr. Yip as Chief Financial Officer of the Company effective September 30, 2020.Additionally, Pretivm announces that Kenneth C. McNaughton, Vice President and Chief Exploration Officer, has informed the Company that...

Juggernaut Update on Empire Property

Written by Customer Service on September 25, 2020. Posted in Public Companies.

VANCOUVER, British Columbia, Sept. 25, 2020 (GLOBE NEWSWIRE) — Juggernaut Exploration Ltd. (TSX-V: JUGR) (OTCQB: JUGRF) (FSE: 4JE) (the “Company” or “Juggernaut”) is pleased to announce amended terms for the 100% controlled Empire property. All future cash payments totalling $3,500,000 have been removed entirely and as per the existing agreement, the issuance of 4,100,000 shares by March 30, 2021, have been reduced significantly to 1,700,000 shares and warrants. $11,500,000 in exploration costs to be incurred by December 31, 2023, has been reduced to $500,000 in aggregate on the Empire and/or Midas properties by December 15, 2022. As per the existing agreement, the issuance of 4,100,000 shares upon the completion of feasibility on the Empire property by March 30, 2025 has now been extended to December 15, 2027 (optional). The warrants...

Aquestive Therapeutics Receives Complete Response Letter from FDA for Libervant™ (diazepam) Buccal Film for Management of Seizure Clusters

Written by Customer Service on September 25, 2020. Posted in Public Companies.

Complete Response Letter cites exposure levels (Cmax) in certain weight groupsNo additional clinical studies anticipated by AquestiveNo Clinical Safety issues or Non-Clinical Chemistry, Manufacturing and Controls (CMC) issues identifiedConference call and webcast today at 6:30 p.m. ETWARREN, N.J., Sept. 25, 2020 (GLOBE NEWSWIRE) — Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharmaceutical company focused on developing and commercializing differentiated products that address patients’ unmet needs and solve therapeutic problems, announced today that the U.S. Food and Drug Administration (FDA) has issued a complete response letter (CRL) regarding the New Drug Application (NDA) for Libervant™ (diazepam) Buccal Film for management of seizure clusters. The FDA issues a CRL to indicate that the review cycle for an application is complete...

Artesian Resources Corporation announces a 3% increase in Common Stock Dividend

Written by Customer Service on September 25, 2020. Posted in Public Companies.

NEWARK, Del., Sept. 25, 2020 (GLOBE NEWSWIRE) — Artesian Resources Corporation (NASDAQ: ARTNA) announced today that its Board of Directors has approved a 3% increase in the company’s Class A and Class B Common Stock dividend, raising the annual dividend to $1.0284 per share. The quarterly dividend of $0.2571 is payable November 20, 2020 to shareholders of record at the close of business on November 9, 2020.“We are pleased to announce this 3% dividend increase. Our Artesian team continues to work diligently to expand our water and wastewater businesses significantly, while generating strong financial results. We look forward to continuing our successful acquisitions, growing our customer base and increasing our revenues to provide consistent returns to our shareholders,” said Dian C. Taylor, Chair, President and CEO.Artesian Resources...

Vigil Health Solutions Announces Normal Course Issuer Bid

Written by Customer Service on September 25, 2020. Posted in Public Companies.

VICTORIA, British Columbia, Sept. 25, 2020 (GLOBE NEWSWIRE) — Vigil Health Solutions Inc. (“Vigil” or the “Company”) (TSX-VEN: VGL) announced today that the TSX Venture Exchange (the “Exchange”) has accepted a notice of intention to make a normal course issuer bid (the “Bid”). Pursuant to the notice accepted by the Exchange, the Company may, during the period commencing September 30, 2020 and ending September 29, 2021, purchase for cancellation, through the facilities of the Exchange and alternative Canadian trading systems, at the market price of the Company’s common shares (“Common Shares”) at the time of purchase, up to 900,000 Common Shares representing 4.95% of the Company’s issued and outstanding Common Shares. In accordance with the policies of the Exchange, a purchase of Common Shares under the Bid may not, when aggregated...

KemPharm Files Preliminary Proxy for Special Meeting of Stockholders

Written by Customer Service on September 25, 2020. Posted in Public Companies.

CELEBRATION, Fla., Sept. 25, 2020 (GLOBE NEWSWIRE) — KemPharm, Inc. (KemPharm, or the Company) (OTCQB: KMPH), a specialty pharmaceutical company engaged in the discovery and development of proprietary prodrugs, today filed a preliminary proxy statement on Schedule 14A (the Preliminary Proxy Statement) with the U.S. Securities and Exchange Commission (SEC) to hold a special meeting of stockholders to authorize a potential reverse stock split of the Company’s common stock (the Special Meeting). If authorized, and subsequently if the Company’s Board of Directors determines that business conditions warrant making it effective, this reverse stock split would potentially reduce the number of common shares outstanding and thereby increase the bid price of KemPharm’s common stock to a level which would potentially allow the Company to meet...

Candelaria Completes Shares for Debt Transaction

Written by Customer Service on September 25, 2020. Posted in Public Companies.

VANCOUVER, British Columbia, Sept. 25, 2020 (GLOBE NEWSWIRE) — Candelaria Mining Corp. (TSXV:CAND, OTC PINK:CDELF) (the “Company”) announces it has closed the previously announced shares for debt transaction and issued 2,175,030 common shares of the Company in settlement of $1,087,515 of indebtedness. The common shares issued pursuant to the debt settlement are subject to a four month hold period expiring on January 26, 2021.About Candelaria MiningCandelaria Mining is a Canadian-based gold development and exploration company with a portfolio of highly prospective projects in Mexico, one of the world’s best mining jurisdictions. Candelaria’s 100% owned Caballo Blanco Project hosts an Indicated Resource of 521,000 ounces of gold and 2,170,000 ounces of silver (31,220,000 tonnes grading 0.52 g/t gold and 2.16 g/t silver) and an Inferred...

UMH PROPERTIES, INC. WILL HOST THIRD QUARTER 2020 FINANCIAL RESULTS WEBCAST AND CONFERENCE CALL

Written by Customer Service on September 25, 2020. Posted in Public Companies.

FREEHOLD, NJ, Sept. 25, 2020 (GLOBE NEWSWIRE) — UMH Properties, Inc. (NYSE:UMH), a real estate investment trust (REIT) specializing in manufactured home communities, announced that it will host its Third Quarter 2020 Financial Results Webcast and Conference Call. Senior management will discuss the results, current market conditions and future outlook on Thursday, November 5, 2020, at 10:00 a.m. Eastern Time.UMH’s Third Quarter 2020 results will be released on Wednesday, November 4, 2020, after the close of trading on the New York Stock Exchange, and will be available on the Company’s website at www.umh.reit, in the “Financial Information & Filings” section.To participate in the webcast, select the microphone icon found on the homepage www.umh.reit. Interested parties can also participate via conference call by calling toll...

Day: September 25, 2020

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice